GLIOBLASTOMA, ADULT
Clinical trials for GLIOBLASTOMA, ADULT explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA, ADULT trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a pill that starves tumors of oxygen help fight advanced cancer?
Disease control OngoingThis early-stage trial is testing an experimental drug called belzutifan in people with advanced solid tumors that have not responded to standard treatments. Belzutifan works by blocking a protein (HIF-2α) that tumors use to survive in low-oxygen conditions. The main goal is to f…
Matched conditions: GLIOBLASTOMA, ADULT
Phase: PHASE1 • Sponsor: Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Laser and immunotherapy combo takes on recurrent brain tumors
Disease control OngoingThis study tests a combination of laser heat therapy (LITT) and the immunotherapy drug pembrolizumab in 32 adults with recurrent glioblastoma, an aggressive brain cancer. The laser heats and destroys hard-to-reach tumors, while pembrolizumab helps the immune system fight cancer c…
Matched conditions: GLIOBLASTOMA, ADULT
Phase: PHASE1, PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC